AT1-receptor autoantibodies, accelerated hypertension, vascular and renal damage: an autoimmune disease?
Regolisti, G.
Giornale Italiano di Nefrologia Organo Ufficiale Della Societa Italiana di Nefrologia 25(1): 11
2008
ISSN/ISBN: 0393-5590 PMID: 18264912 Document Number: 617852
Document emailed within 1 workday
Related Documents
Gorostidi, M.; Marín, R. 2004: Renal vascular disease. Concept and meaning. Epidemiology. Essential arterial hypertension and renal failure. Nephrosclerosis. Ischemic or atherosclerotic nephropathy Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 73-83; 187-235Cui, Z.; Zhao, M.-h. 2005: Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage Zhonghua Yi Xue Za Zhi 85(13): 903-907
Dominguez, M.; Cacoub, P.; Garcia de la Torre, I.; Piette, T.J.; Salazar-Paramo, M.; Godeau, P.; Angleés-Cano, E. 2001: Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases Journal of Rheumatology 28(2): 302-308
Mamula, M.J.; Jemmerson, R.; Hardin, J.A. 1990: The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease Journal of Immunology 144(5): 1835-1840
Chablani, A.T.; Badakere, S.S.; Bhatia, H.M. 1987: Non-organ specific autoantibodies associated with auto-immune haematologic disorders and systemic autoimmune disease Indian Journal of Medical Research 86: 337-342
Montes Santiago, J.; Gambón Deza, F.; García García, M.J.; González Vázquez, L.; Hermo Brión, J.A.; Pérez Alvarez, R. 2000: Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations Anales de Medicina Interna 17(7): 343-346
Gómez-Fernández, P.; Pérez-Requena, J.; Sánchez-Margalet, V.; Esteban, J.; Murillo-Carretero, M.; Almaraz-Jiménez, M. 2005: Vascular damage in chronic renal failure. the increase of vascular nitrotyrosine and cytochines accumulation is accompanied by an increase of endothelial nitric oxide synthase (eNOS) expression Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(2): 155-162
Golding, B.; Golding, H.; Foiles, P.G.; Morton, J.I. 1983: CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice Journal of Immunology 130(3): 1043-1046
Kostyukevich, M.V.; Zykov, K.A.; Mironova, N.A.; Agapova, O.Y.; Shevelev, A.Y.; Efremov, E.E.; Vlasik, T.N.; Golitsyn, S.P. 2016: Role of Autoantibodies Against 1-Adrenergic Receptor in Cardiovascular Disease Kardiologiia 56(12): 82-91
González de Pijem, L.; Nieves-Rivera, F. 2001: Insulin autoantibodies: evidence of autoimmune disease among a group of Puerto Rican children with newly diagnosed type 1 diabetes mellitus Puerto Rico Health Sciences Journal 20(2): 161-164
Ploth, D.W. 1990: Influences of angiotensin on renal function in renal vascular hypertension Kidney International. Suppl 30: S97-101
Borne AE von dem; Engelfriet, C.P.; Beckers, D.; van Loghem, J.J. 1971: Autoimmune haemolytic anaemias. IV. Biochemical studies of red cells from patients with autoimmune haemolytic anaemia with incomplete warm autoantibodies Clinical and Experimental Immunology 8(3): 377-388
Falqui, V.; Viazzi, F.; Leoncini, G.; Ratto, E.; Parodi, A.; Conti, N.; Tomolillo, C.; Deferrari, G.; Pontremoli, R. 2007: Blood pressure load, vascular permeability and target organ damage in primary hypertension Journal of Nephrology 20(Suppl): S63-S67
Rhodes, M.L.; Smith, J.D. 1977: The lung in autoimmune collagen vascular disease (A-CVD) Heart and Lung: the Journal of Critical Care 6(4): 653-659
Heesen, W.F.; Beltman, F.W.; Smit, A.J.; May, J.F.; de Graeff, P.A.; Havinga, T.K.; Schuurman, F.H.; van der Veur, E.; Meyboom-de Jong, B.; Lie, K.I. 1998: Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension Journal of Cardiovascular Pharmacology 31(2): 187-194
Lekston, A.; Chudek, J.; Gasior, M.; Wilczek, K.; Wiecek, A.; Kokot, F.; Szyguła-Jurkiewicz, B.; Wojnicz, R.; Osuch, M.; Poloński, L. 2008: Comparison of early and long-term impact of percutaneous transluminal renal artery angioplasty alone or with brachytherapy on renal function in patients with reno-vascular hypertension Kardiologia Polska 66(10): 1061-1066; Discussion: 1067-1068
Heber-Katz, E. 1991: The autoimmune T-cell receptor in experimental disease Immunology Series 55: 155-169
Zhou, F.; Liu, Y.; Zou, W.; Zhang, Y.; Wang, H. 2001: Malignant hypertension presenting with renal damage: a clinical and pathological analyses Zhonghua Nei Ke Za Zhi 40(3): 165-168
Song, H.; Tasaki, H.; Yashiro, A.; Okazaki, M.; Ioka, T.; Taniguchi, H.; Nakashima, Y. 2001: Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure Clinical Nephrology 56(5): 346-352
Schiffrin, E.L. 2002: Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers Canadian Journal of Cardiology 18 Suppl A: 15a-18a